An opioid efficacy switch for reversible optical control of analgesia
Azo-morphine-3 (AM-3) is a photoswitchable ligand that toggles mu-opioid receptor activity between low and high efficacy states, working in vitro and in vivo in both brain and periphery. Light-driven switching gave spatiotemporally precise control of analgesia across pain models with reduced side effects compared with systemic drugs. It also serves as a tool to probe the structural basis of opioid efficacy.
Why it matters: It offers reversible optical control of opioid analgesia with fewer side effects than systemic drugs.
